Announcements Trials
Browse Landscape

Phase

Phase 2 6

Status

Completed 5Withdrawn 1

Sponsor Class

NIH 8OTHER 6INDUSTRY 5NETWORK 1

Study Type

Interventional 6

Sponsor

Cancer Type

Gastrointestinal 3Thoracic 1Gynecologic 1Dermatologic 1

Conditions

Rectal Neoplasms 2Colorectal Neoplasms 2Colonic Neoplasms 2Uterine Cervical Neoplasms 1Pancreatic Neoplasms 1Melanoma 1Lung Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Adenocarcinoma, Bronchiolo-Alveolar 1Adenocarcinoma of Lung 1

Interventions

Cyclophosphamide 2067Radiotherapy 1990Cisplatin 1856Carboplatin 1560Gemcitabine 1454Paclitaxel 1320Bevacizumab 1320pembrolizumab 1238Docetaxel 1227Oxaliplatin 1184Capecitabine 1178Fluorouracil 1083Dexamethasone 979Magnetic Resonance Spectroscopy 971Nivolumab 936Rituximab 929Drug Therapy 915Surveys and Questionnaires 899Doxorubicin 845Etoposide 843Radiosurgery 816Blood Specimen Collection 816Irinotecan 784Cytarabine 743fludarabine 726Leucovorin 684Surgical Procedures, Operative 640Lenalidomide 618Biopsy 594fludarabine phosphate 569

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
OTHER × irofulven × Clear all
NCT00003441 2018-10-25

Irofulven in Treating Patients With Metastatic Colorectal Cancer

M.D. Anderson Cancer Center

Phase 2 Completed
26 enrolled
Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT00003666 2016-07-20

Irofulven in Treating Patients With Relapsed or Refractory Non-small Cell Lung Cancer

Alliance for Clinical Trials in Oncology

Phase 2 Completed
36 enrolled
Thoracic

Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00003786 2014-03-07

Irofulven in Treating Patients With Metastatic or Recurrent Colorectal Cancer

University of Chicago

Phase 2 Withdrawn
Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT00005070 2013-06-19

Irofulven in Treating Patients With Stage IVB or Recurrent Cervical Cancer

Memorial Sloan Kettering Cancer Center

Phase 2 Completed
Gynecologic

Uterine Cervical Neoplasms

NCT00005968 2013-05-30

Irofulven in Treating Patients With Stage IV Melanoma

University of Colorado, Denver

Phase 2 Completed
Dermatologic

Melanoma

NCT00003760 2012-08-09

Irofulvene in Treating Patients With Stage III or Stage IV Pancreatic Cancer

The University of Texas Health Science Center at San Antonio

Phase 2 Completed
3 enrolled
Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡